A cohort study on anticoagulant therapy risks in dental patients after multiple extractions

Minerva Dent Oral Sci. 2021 Oct;70(5):196-205. doi: 10.23736/S2724-6329.21.04551-4.

Abstract

Background: Due to technology and pharmaceutical science and increasing life expectancy, the patient population is continuously aging. Patients requiring dental extractions often have systemic and/or chronic diseases and are undergoing polypharmacologic therapy. Oral surgeons often interface with patients who perform anticoagulant therapy. The main aim of this study was to clarify what the contraindications and short-/long-term complications may be.

Methods: A sample of 298 patients (mean age 58 years) who required multiple surgical dental extractions has been taken in consideration. Patients were divided into groups and subgroups according to the anticoagulant drug therapy.

Results: Long-term complications represented variable bleeding between groups from 8 hours to 7 days after surgery. The One-Way ANOVA Test was used to compare the results between groups. Patients treated with direct oral anticoagulants showed fewer intraoperative problems, but further studies and further collaboration between doctors, cardiologists and oral dentists/surgeons are certainly needed to manage these patients in a predictable manner.

Conclusions: This study showed that using direct oral anticoagulants drugs results in few intraoperative bleeding, less postoperative hemorrhagic complications, and an easier administration of the drugs respect vitamin K antagonists, with mild and manageable complications.

MeSH terms

  • Anticoagulants* / adverse effects
  • Cohort Studies
  • Humans
  • Middle Aged
  • Tooth Extraction*

Substances

  • Anticoagulants